JB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, J.
Right arrow Articles by Howe, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, J.
Right arrow Articles by Howe, M. M.
Journal of Bacteriology, December 2004, p. 7858-7864, Vol. 186, No. 23
0021-9193/04/$08.00+0     DOI: 10.1128/JB.186.23.7858-7864.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Binding of the C-Terminal Domain of the {alpha} Subunit of RNA Polymerase to the Phage Mu Middle Promoter

Ji Ma and Martha M. Howe*

Department of Molecular Sciences, University of Tennessee Health Science Center, Memphis, Tennessee

Received 31 March 2004/ Accepted 27 August 2004


   ABSTRACT
Top
 Abstract
Introduction
 Materials and Methods
 Results and Discussion
 References
 
The C-terminal domain of the {alpha} subunit ({alpha}CTD) of Escherichia coli RNA polymerase is often involved in transcriptional regulation. The {alpha}CTD typically stimulates transcription via interactions with promoter UP element DNA and transcriptional activators. DNase I footprinting and gel mobility shift assays were used to look for potential interaction of the {alpha}CTD with the phage Mu middle promoter Pm and its activator protein Mor. Binding of RNA polymerase to Pm in the presence of Mor resulted in production of a DNase I footprint downstream of Mor due to open complex formation and generation of a second footprint just upstream of the Mor binding site. Generation of the upstream footprint did not require open complex formation and also occurred in reactions in which the {alpha}CTD or His-{alpha} proteins were substituted for RNA polymerase. In gel mobility shift assays, the formation of a supershifted ternary complex demonstrated that Mor and His-{alpha} bind synergistically to Pm DNA. Gel shift assays with short DNA fragments demonstrated that only the Mor binding site and a single upstream {alpha}CTD binding site were required for ternary complex formation. These results suggest that the {alpha}CTD plays a role in Pm transcription by binding to Pm DNA just upstream from Mor and making protein-protein interactions with Mor that stabilize the binding of both proteins.


   INTRODUCTION
Top
 Abstract
 Introduction
Materials and Methods
 Results and Discussion
 References
 
Transcription in prokaryotes is carried out by RNA polymerase holoenzyme, which is composed of a core enzyme ({alpha}2ßß'{omega}) capable of nonspecific DNA binding and one of several {sigma} subunits that confer promoter specificity (for reviews, see references 16, 25, 35, 36, and 40). The {alpha} subunit, which consists of two domains connected by a flexible linker (7, 37), plays important roles in polymerase assembly and transcriptional regulation. The {alpha} N-terminal domain ({alpha}NTD) contains determinants for dimer formation and serves to initiate core assembly by sequential binding of ß and ß' to the {alpha} dimer (20, 52). The {alpha} C-terminal domain ({alpha}CTD) contains determinants for DNA binding and interaction with a number of transcriptional activators (10, 13, 15, 19). The binding of the {alpha}CTD to promoter DNA generally occurs upstream of the core promoter, but its precise location varies depending on both the promoter sequence and the binding of transcriptional regulatory proteins (6, 33, 34).

Typical factor-independent promoters contain –35 and –10 hexamers that are separated by a 16- to 18-nucleotide spacer region (17) and are contacted by the primary or "housekeeping" sigma factor {sigma}70 (9, 25). In addition to the core promoter sequences described above, strong promoters often contain an AT-rich UP element that is located upstream of the –35 hexamer and binds the {alpha}CTD (15, 41). In promoters that respond to activators, the –35 hexamer is usually poor, and activator binding to the promoter often facilitates or stabilizes RNA polymerase binding, a process called RNAP recruitment (9, 19). Other activators stimulate isomerization from a closed complex to an open complex which is capable of transcription initiation (18, 19, 32). In simple Class I activator-dependent promoters, the activator generally binds in the –60 region and contacts the {alpha}CTD, which is then bound between the activator and the remainder of RNAP (9, 19, 33, 40, 43). In simple Class II promoters, the activator generally binds in the –40 region and interacts with the C-terminal domain of {sigma} ({sigma}CTD) or with both the {sigma}CTD and the {alpha}CTD, which is then bound upstream of the activator (9, 19, 26). At Class II promoters, the {alpha}NTD can also serve as a target for interaction with CAP, the catabolite activator protein (38).

During lytic development of bacteriophage Mu, a regulatory cascade of activator proteins controls synthesis of the middle and late transcripts by the Escherichia coli RNA polymerase holoenzyme containing {sigma}70 (14, 27-31, 51). Whereas the early promoter Pe is recognized directly by the host RNAP (22), the middle promoter Pm and late promoters Plys, PI, PP, and Pmom lack recognizable –35 hexamers (28, 30, 47) and require activation by the Mu Mor and C proteins, respectively (28-30).

The 129-amino-acid Mor protein forms an intertwined symmetrical dimer (23) and binds to an imperfect inverted-repeat dyad-symmetry element centered at –43.5 in Pm (2, 30). Activation of transcription from Pm by Mor requires both the {sigma}CTD and {alpha}CTD of RNA polymerase (3), making Pm a Class II activator-dependent promoter. Random mutagenesis of Pm from –70 to +10 revealed three regions important for Pm function: the –10 region, the Mor binding site from –51 to –36, and bases –31 to –29 in the spacer region, which may be involved in open complex formation (2, 4). Mutations in the region upstream of –51 had much less dramatic effects on Pm activity, but a –57 G-to-T mutation resulted in a twofold increase in activity, and a –54 A-to-T mutation reduced activity by half (1), suggesting a possible role for this region in Pm function.

Several lines of evidence suggest that the {alpha}CTD of RNAP may bind to Pm upstream of Mor and participate in transcription activation: (i) in vitro transcription experiments demonstrated that deletion of the {alpha}CTD decreased Pm activity dramatically (3); (ii) a short DNase I footprint upstream from the Mor binding site appeared only when Mor and RNA polymerase were both present (3); (iii) a yeast interaction trap assay showed that Mor and the {alpha}CTD can interact with each other (3); and (iv) deletion analysis demonstrated that AT-rich sequences between –62 and –52 are important for full activity of Pm (2, 21). In this study, results from DNase I footprinting and gel mobility shift experiments demonstrate that the {alpha}CTD is the only polymerase component needed to generate the footprint just upstream from Mor and that Mor and the {alpha}CTD bind synergistically.


   MATERIALS AND METHODS
Top
 Abstract
 Introduction
 Materials and Methods
Results and Discussion
 References
 
Media, chemicals, and enzymes. Luria-Bertani broth and agar (46) were used for standard bacterial growth; ampicillin at 50 µg/ml (US Biochemical Corp., Cleveland, Ohio) and chloramphenicol at 25 µg/ml (Sigma Chemical Co., St. Louis, Mo.) were added when necessary. Isopropyl-ß-D-thiogalactopyranoside (IPTG) was obtained from US Biological. Radiolabeled compounds were from Perkin-Elmer Life Science (Boston, Mass.). In general, buffer components were obtained from Sigma Chemical Co., and gel reagents were purchased from Bio-Rad Laboratories (Hercules, Calif.). Phenol and phenol-chloroform were from Amresco Inc. (Solon, Ohio). DNase I (type II from bovine pancreas) was obtained from Sigma Chemical Co.; bovine serum albumin, phage T4 polynucleotide kinase (PNK), and deoxynucleoside triphosphates were purchased from Promega Corp. (Madison, Wis.). The enzymes Taq DNA polymerase, T4 DNA ligase, and shrimp alkaline phosphatase were from Roche (Basel, Switzerland). SeaKem ME and NuSieve GTG agarose were from FMC BioProducts (Rockland, Maine). The Ni-nitrilotriacetic acid column used for purifying the His-tagged {alpha} subunit of RNAP was from QIAGEN Inc. (Valencia, Calif.). Bench Mark protein size markers and low-DNA-mass ladder markers were obtained from Gibco-BRL Invitrogen (Carlsbad, Calif.). Oligonucleotides were purchased from Integrated DNA Technologies, Inc. (Coralville, Iowa).

Bacterial strains and plasmids. Plasmid-containing derivatives of strain MH13312 [mcrA {Delta}proAB-lac thi gyrA endA hsdR relR supE44 recA/F' (pro+ lacIq1 {Delta}lacZY)] were used for isolation of plasmid DNA; MH13312 is a derivative of JM109 that contains an F' pro+-lac element with lacIq1 and {Delta}lacZY mutations (2). Strain RLG3538 [F– ompT hsdSB(rB–mB–) gal dcm {lambda}DE3/pLysS/pHTT7f1-NH{alpha}], obtained from W. Ross and R. Gourse, contains plasmid pHTT7f1-NH{alpha} in host strain BL21(DE3) (13), which expresses T7 RNA polymerase under the control of PlacUV5; the plasmid contains the rpoA gene with an N-terminal His6-tag under the control of the T7 gene 10 promoter and was used for overexpression and purification of the His-tagged {alpha} subunit of RNA polymerase (His-{alpha}) (50). Strain MH10713 [ompT hsdSB(rB–mB–) gal dcm {lambda}DE3/pLysS], the Howe lab version of strain BL21(DE3) (31, 48), was transformed with plasmid pKM90 for Mor overproduction. Plasmid pKM90 contains the mor gene under the control of a T7 promoter in the pT7-7 expression vector and was used for overexpression and purification of the Mor activator protein (31).

Plasmid pMM1 was constructed by cloning Pm sequences from –98 to +10 into the EcoRI and BamHI sites of the plasmid vector pIA12; pIA12 is a HindIII linker-containing derivative of pLC1, which is a {Delta}lacY derivative of the promoter cloning vector pRS415 (2, 11, 44); pMM1 was used as the template when Pm probes were made by PCR.

Protein purification. Overexpression and purification of His-{alpha} was performed essentially as described by Tang et al. (50). Strain RLG3538 was induced with IPTG, pelleted by centrifugation, resuspended in buffer A (50), and lysed by sonication, and the extract was clarified by centrifugation. Soluble His-{alpha} was purified by binding to Ni2+-nitrilotriacetic acid agarose beads, then washing with buffer A containing 20 mM imidazole, and eluting with buffer A containing 500 mM imidazole. After dialysis against storage buffer (25 mM Tris-HCl, pH 7.9, 100 mM NaCl, 0.1 mM EDTA, 0.1 mM dithiothreitol [DTT], 50% glycerol), the protein was aliquoted and stored at –20°C. The His-{alpha} concentration was determined by using a Bradford assay (8).

Mor protein was overexpressed in a strain made just before use by transformation of pKM90 into strain MH10713. Following sonication and centrifugation to remove cell debris, Mor protein was purified from the cell extract by sequential polyethyleneimine precipitation, ammonium sulfate precipitation (20%), and heparin agarose chromatography as described previously (2 and was generously provided by Y. Mo. The His-{alpha}CTD protein was overexpressed from a pET-28a (Novagen, EMD Biosciences) clone containing the sequence encoding amino acids 245 to 329 of the {alpha}CTD fused to a His6 tag and thrombin cleavage site and located downstream from a T7 promoter. The His-{alpha}CTD protein was purified by Ni2+ affinity chromatography followed by size exclusion chromatography (Superdex 75); untagged {alpha}CTD was made by thrombin cleavage of the purified His-{alpha}CTD protein followed by Ni2+ affinity chromatography and size exclusion chromatography (Superdex 75). Purified His-{alpha}CTD and untagged {alpha}CTD were generously provided by M. Kumaraswami. Figure 1 shows a sodium dodecyl sulfate (SDS)-polyacrylamide gel (42) run with samples of each purified protein and stained with Coomassie brilliant blue dye.



View larger version (60K):
[in this window]
[in a new window]
  		FIG. 1. An SDS-polyacrylamide gel containing samples of the purified proteins. Approximately 2.5 µg of each purified protein was subjected to electrophoresis on an SDS-polyacrylamide gel (12% acrylamide) and stained with Coomassie blue R250. Lanes were loaded with the following: protein markers whose masses (in kDa) are indicated at the left, lane 1; Mor, lane 2; His-{alpha}CTD, lane 3; {alpha}CTD, lane 4; and His-{alpha}, lane 5.

 
Probe preparation. The 198-bp probe used for DNase I footprinting was generated by PCR using vector primers IRI21 (TGGGGATCGGAATTATCGT) and IRI22 (AACTGGCGGCTGTGGGATT), one of which was radiolabeled by T4 PNK using [{gamma}-32P]ATP (3,000 Ci/mmol), with plasmid pMM1 (containing Pm –98 to +10) DNA as template. After purification using a Qiaquick spin PCR purification kit (QIAGEN), probe concentration was estimated by comparing band intensities against a low-DNA-mass ladder run in parallel on a 2% agarose gel stained with ethidium bromide (42).

Short probes used in gel retardation assays were made by annealing pairs of oligonucleotides for 3 min at 55 or 60°C after preincubation for 5 min at 90°C. One strand of each pair was 5'-end-labeled with {gamma}-32P using T4 PNK and [{gamma}-32P]ATP (3,000 Ci/ml) prior to annealing. Probes were purified using a Qiaquick nucleotide removal kit (QIAGEN) before their concentrations were estimated by comparison to a low-DNA-mass ladder on a 4% agarose gel. Oligonucleotide pairs consisted of complementary sequences (top and bottom strands) containing the following Pm positions numbered relative to the transcription start site as +1: JM19-JM20, –54 to –21; JM21-JM22, –61 to –31; JM35-JM37, –57 to –31; and JM36-JM38, –59 to –31.

DNase I footprinting. The binding reactions contained 1 to 2 ng of labeled probe and were performed in a total volume of 40 µl of binding buffer containing 20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, 2 mM CaCl2, 1 mM DTT, 20 ng of bovine serum albumin/µl, 1 ng of calf thymus DNA/µl, and 7% glycerol. Various amounts of reconstituted RNAP (generously provided by W. Ross and R. Gourse), His-{alpha}, His-{alpha}CTD, untagged {alpha}CTD, or Mor were added to binding reactions in amounts based on binding efficiencies observed previously (2, 3, 7, 13, 50). Mor was always incubated with the probe for 3 to 10 min prior to addition of a second protein. After incubation, the reaction mixtures were treated with 4.5 ng of DNase I at room temperature for 20 to 45 s (depending on the proteins present), and reactions were stopped by addition of 50 µl of stop solution (3). The mixture was brought up to 200 µl with H2O, extracted with phenol-chloroform, ethanol precipitated, washed with 70% ethanol, dried, and resuspended in loading buffer (42). Markers were generated by carrying out a Maxam-Gilbert G-only sequencing reaction with a similar probe (42). The products were separated by electrophoresis on a 6% sequencing gel (42) and visualized by autoradiography with Kodak BioMax film with or without an intensifying screen.

Gel mobility shift assays. Gel shift assays were done using probes made by annealing primer pairs JM19-JM20, JM21-JM22, JM35-JM37, or JM36-JM38. Binding reactions were performed in 20 µl of buffer containing 20 mM Tris-HCl (pH 7.9), 50 mM NaCl, 1 mM DTT, 10% glycerol, and 0.7 to 2.0 nM labeled probe. Different amounts of Mor were added to achieve final concentrations of 68 nM and 136 nM, and the mixtures were incubated for 10 min at 30°C. Various amounts of purified His-{alpha}, His-{alpha}CTD, or {alpha}CTD were added, and incubation continued for another 10 min at 30°C. Mixtures were loaded onto 15-cm-long 6% acrylamide native gels containing 10% glycerol and 0.5x Tris-borate-EDTA buffer and subjected to electrophoresis in 0.5x Tris-borate-EDTA buffer containing 2% glycerol at 3°C for 2 to 3 h at 200 V (13). The gels were exposed to X-OMAT AR film (Kodak) without drying and with or without an intensifying screen.

Gel shift assays were also performed with the same 198-bp probes used for DNase I footprinting. In that case, 4% acrylamide gels were used, and electrophoresis was carried out for 1.5 h at 230 V.


   RESULTS AND DISCUSSION
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
References
 
DNase I footprinting of Pm with RNA polymerase. Previous DNase I footprinting with purified Mor and Pm DNA probe (3, 21) showed that Mor protected Pm positions –56 to –33 from digestion by DNase I (Fig. 2). The addition of RNA polymerase led to extension of the footprint downstream to at least +14 and the appearance of a new upstream footprint spanning positions –61 to –59 (3). The extended downstream footprint was probably due to open complex formation, since similar long footprints are typically found in open complexes (24, 39, 49), and melting of Pm DNA from –12 to –1 was detected by KMnO4 footprinting of these complexes (4). It seemed most likely that the upstream footprint would result from binding of the {alpha}CTD of RNA polymerase to this region or from conformational changes in the DNA caused by open complex formation (3, 5, 41).



View larger version (9K):
[in this window]
[in a new window]
  		FIG. 2. Middle promoter sequence and DNase I footprints. The sequence presented is that of the top strand from –66 to +23 of the Mu middle promoter Pm. The –10 hexamer is boxed, and the bent arrow represents the transcript initiating at +1. Dots mark 10-base intervals. The facing arrows identify the most important positions of the imperfect inverted-repeat sequences in the Mor binding site as defined by mutational analysis (2). The extent of the DNase I footprints observed due to binding of Mor alone or Mor and RNAP together are indicated by thick black bars. The sequences contained in short fragments used for gel mobility shift assays are shown by lines below the Pm sequence.

 
DNase I footprinting assays were used to distinguish between these possibilities. First, DNase I footprinting was performed at 30°C using a 198-bp DNA fragment containing Pm sequences –98 to +10, purified Mor protein, and two in vitro reconstituted RNA polymerases: wild-type RNAP and RNAP containing {alpha} subunits that were truncated at amino acid 235 and therefore deleted for the {alpha}CTD (RNAP{Delta}{alpha}CTD) (Fig. 3). The footprint patterns for Mor alone and for Mor with wild-type RNAP at 30°C (Fig. 3B) were similar to those observed previously (3) and represent extended, heparin-resistant, open complexes melted from –12 through +4 (Y. Mo, personal communication). (Complete clearing of the downstream footprint was observed in other experiments [Y. Mo, personal communication]). Incubation of probe with RNAP alone caused only subtle changes in the DNase I band pattern (including slight hypersensitivity at –51 and –44 and slight protection at –36, –37, –23, and –24), indicating that any interactions between RNAP and Pm DNA in the absence of Mor were unstable. When footprinting was done with Mor and RNAP lacking the {alpha}CTD, neither the upstream nor the downstream footprints appeared (Fig. 3B), demonstrating that the {alpha}CTD was essential for stable binding of RNAP to Pm. Interestingly, the subtle changes in banding pattern observed with wild-type RNAP alone were also not observed with the deleted RNAP, suggesting that the {alpha}CTD may participate in the unstable RNAP-Pm DNA interactions as well.



View larger version (105K):
[in this window]
[in a new window]
  		FIG. 3. DNase I footprinting of Pm with wild-type RNAP and RNAP lacking the {alpha}CTD. Before digestion by DNaseI linear 198-bp probe DNA, 5'-end-labeled on the top strand, was incubated for 10 min with 800 nM Mor; 30 (+), 60 (++), or 80 (+++) nM wild-type (WT) or mutant ({Delta}{alpha}CTD) RNAP reconstituted in vitro; or both Mor and RNAP. When both proteins were used, Mor was incubated with the probe for 3 min before RNAP was added; then incubation was continued for 10 min prior to DNase I treatment. The regions protected by Mor and RNAP are indicated by brackets, and the upstream footprint is indicated by a black bar. The numbers to the right of each panel correspond to positions in the Pm sequence, which are numbered relative to the transcription start site as +1. The presence or absence of protein is indicated by a + or –, respectively. Panel A also contains the products of a G-only Maxam-Gilbert sequencing reaction performed on a similar probe (differing only by the presence of additional Mu Pm sequence from +11 to +46) to serve as markers for determining the lengths of the DNase I fragments; the G-ladder fragments migrate 1.5 nucleotides faster than the corresponding DNase I fragments (45). Panels B and C contain DNase I digestion products generated by protein binding and DNase I digestion performed at 30 and 15°C, respectively.

 
To test whether the upstream footprint was caused by open complex formation, we repeated the DNase I footprinting at 15°C, since no open complex formation was observed in previous KMnO4 footprinting experiments performed at 15°C (data not shown). The Mor footprint was the same as that observed at 30°C (Fig. 3C), and there was no extension of the footprint downstream when wild-type RNA polymerase was added, consistent with the absence of an open complex at 15°C. In contrast, the upstream footprint from –61 to –59 was still present, demonstrating that it is not open complex formation that generates the footprint. In other experiments performed similarly, the upstream footprints were sensitive to heparin (Y. Mo, personal communication), suggesting that they are in unstable closed complexes (24, 32). When RNAP lacking the {alpha}CTD was assayed, there was no upstream or downstream protection at all, again indicating that the {alpha}CTD is required for generation of both footprints.

DNase I footprinting of Pm with His-{alpha}, His-{alpha}CTD, and {alpha}CTD. From the results of the above DNase I footprinting experiments, we concluded that the {alpha}CTD is essential for generation of the upstream footprint and that open complex formation is not required. To distinguish whether other RNAP subunits were involved or whether the {alpha}CTD was sufficient, we assayed for upstream protection from DNase I cleavage in experiments using purified His-{alpha}, His-{alpha}CTD, or untagged {alpha}CTD instead of RNA polymerase.

In the presence of Mor, all three {alpha}CTD-containing proteins generated an upstream footprint identical to that produced by the wild-type RNA polymerase at 15°C (Fig. 4). The footprint patterns observed with purified {alpha}CTD, His-{alpha}CTD, and His-{alpha} were indistinguishable, indicating that the {alpha}NTD was not required for {alpha}CTD binding and that the His tags did not interfere with binding. In the absence of Mor, none of the {alpha}CTD-containing proteins produced any detectable change in the DNase I band pattern. This experiment demonstrated that interactions between the {alpha}CTD, Mor, and DNA were both necessary and sufficient to generate the upstream footprint.



View larger version (85K):
[in this window]
[in a new window]
  		FIG. 4. DNase I footprinting of Pm with His-{alpha}, His-{alpha}CTD, and {alpha}CTD. About 2 ng of the same probe used for Fig. 3B and C was incubated with 800 nM Mor, 9 µM His-{alpha}, 35 µM His-{alpha}CTD, or 50 µM {alpha}CTD for 10 min at 30°C. When Mor was used with His-{alpha}, His-{alpha}CTD, or {alpha}CTD, Mor was incubated with the probe for 5 min at 30°C prior to addition of the second protein, and incubation then continued for 10 min at 30°C prior to treatment with DNase I. The lane marked G contains the products of a G-only Maxam-Gilbert sequencing reaction performed on the same probe used for Fig. 3A. The Pm positions corresponding to the G-ladder bands are indicated on the right, and those for the DNase I digestion products are indicated on the left.

 
Gel mobility shift assay of His-{alpha} binding to Pm. In DNase I footprinting experiments performed with less than saturating amounts of Mor protein, the Mor footprints were more clear in the presence of RNAP than in its absence (data not shown), leading us to think that Mor and RNAP might bind synergistically to Pm DNA, using protein-protein interactions to stabilize the binding of both proteins to the DNA. To test whether Mor and His-{alpha} might exhibit synergistic binding, we performed gel shift assays with the same labeled Pm DNA fragment used for DNase I footprinting in the presence of each protein, first alone and then together. Binding of Mor to the DNA probe resulted in generation of a typical slower-migrating binary complex, and the amount of complex increased with increasing Mor concentration (Fig. 5A). Binding of {alpha} is weak (7, 13), but a shifted species was observed for His-{alpha} alone when a high concentration was used. When both Mor and His-{alpha} were present, a supershifted species presumably corresponding to a His-{alpha}-Mor-DNA ternary complex was observed, even at low concentrations of Mor and His-{alpha}, concentrations that gave only a barely detectable (Mor) or undetectable (His-{alpha}) shift with each protein alone. When the assay was repeated with Mor and the {alpha}CTD instead of His-{alpha}, similar results were observed (Fig. 5B). In other experiments involving incubation of His-Mor and His-{alpha}CTD with short Pm DNA fragments, the complexes formed were purified and shown by SDS-polyacrylamide gel electrophoresis to contain both His-Mor and His-{alpha}CTD (M. Kumaraswami, personal communication). Therefore, taken together with the results of previous yeast interaction trap assays (3), these experiments demonstrate that Mor and {alpha} do bind synergistically to Pm, forming a stable ternary complex, and that at least part of that synergistic binding is due to interactions between Mor and the {alpha}CTD.



View larger version (37K):
[in this window]
[in a new window]
  		FIG. 5. Gel mobility shift assays of Mor, His-{alpha}, and {alpha}CTD binding to Pm DNA. (A) The same 198-bp probe used for DNase I footprinting was incubated with Mor at 68 (+) or 200 (++) nM or 1 µM (four +'s) or His-{alpha} at 2.7 (+), 5.4 (++), or 10.8 (four +'s) µM, either alone or together. When alone, binding reactions were incubated for 10 min at 30°C; when together, Mor was preincubated with probe for 10 min at 30°C, then His-{alpha} was added, and incubation was continued for 10 min at 30°C prior to loading on the gel. (B) The assay was performed as described for panel A except purified {alpha}CTD was used at a concentration of 30 µM (+) in place of His-{alpha}. A – indicates that no protein was added. Bands corresponding to free probe, the Mor-DNA or His-{alpha}-DNA binary complexes, and the Mor-His-{alpha}-DNA or Mor-{alpha}CTD-DNA ternary complexes are indicated by the labels F, B, and T, respectively, to the left of each panel.

 
Examination of the Pm sequence (Fig. 2) reveals the presence of a second AT-rich region, the stretch of seven T residues at positions –30 through –24, which might serve as an additional binding site for the {alpha}CTD. In the DNase I footprinting experiments, this region had no bands in the DNA-only control lane, making it impossible to detect a footprint if the {alpha}CTD bound there. To test for possible {alpha}CTD binding to that region, we performed gel shift assays with short DNA fragments made by annealing pairs of complementary oligonucleotides. One 31-bp fragment, with Pm sequence –61 to –31, contained the Mor binding site and upstream {alpha}CTD binding site. The second probe, a 34-bp fragment, with Pm sequence –54 to –21, contained the Mor binding site and downstream T tract but lacked the upstream {alpha}CTD binding site. Mor bound normally to both probes (Fig. 6A), but only the –61 to –31 probe containing the upstream binding site gave a supershifted species reflecting binding of both Mor and His-{alpha}. The absence of a supershifted species with the –54 to –21 probe indicates either that the T tract in Pm does not serve as an efficient binding site for {alpha} or that this site is too distant and on a different face of the helix from the Mor binding site, preventing the Mor and His-{alpha} synergistic binding needed for stability of the ternary complex.



View larger version (51K):
[in this window]
[in a new window]
  		FIG. 6. Gel mobility shift assays with short Pm DNA fragments. Double-stranded blunt-ended Pm DNA probes made by annealing of complementary oligonucleotides were incubated with Mor at 68 (+) or 136 (++) nM or 0.5 (+), 1 (++) or 2.7 (four +'s) µM His-{alpha} in 20 µl for 10 min at 30°C. For lanes containing both proteins, 68 nM Mor was incubated with probe for 10 min at 30°C prior to addition of His-{alpha}, and then the mixture was incubated for another 10 min at 30°C before loading on the gel. The notations are the same as those in Fig. 5 except that the Pm sequence contained in each probe is indicated above the set of lanes containing that probe. Panels A and B were done separately with probes of different lengths; the bands below the free probe are probably excess unannealed oligonucleotide.

 
The –61 to –31 probe used in the experiment described above contained 10 bp beyond the end of the Mor dyad-symmetry element (Fig. 2). To determine how much of this region is needed for {alpha}CTD binding, we repeated the gel shift assays with shorter probes containing Pm sequences –59 to –31 and –57 to –31. The longer –59 to –31 probe gave strong supershifted bands comparable to those seen with the –61 to –31 probe, whereas the –57 to –31 probe gave a weaker supershifted species whose migration was retarded much less than that of the others (Fig. 6B). We conclude from this experiment that 7 to 8 bp beyond the Mor dyad-symmetry element are required for efficient ternary complex formation and stability. This length is similar to that of the proximal subsite of the bipartite UP element (12). The short length of the upstream footprint is also consistent with the conclusion that only a single {alpha}CTD is bound and that {alpha}CTD binding occurs just upstream from Mor.

In conclusion, the results of DNase I footprinting and gel mobility shift assays demonstrate that the {alpha}CTD of RNAP binds just upstream of the Mor binding site in Pm, exhibiting synergistic binding with Mor. Given the requirement for the {alpha}CTD for normal Pm activation (3) we predict that these synergistic binding interactions play an important role in the activation process.


   ACKNOWLEDGMENTS
 
This work was supported by National Science Foundation grants MCB-9604653 and MCB-0318108 to M.M.H. and by a Van Vleet Chair of Excellence Professorship to M.M.H.

We thank W. Ross and R. Gourse for their generosity in providing the His-{alpha} overexpression strain and reconstituted RNA polymerases, M. Mitchell for constructing pMM1, and M. Kumaraswami and Y. Mo for their gifts of purified proteins and permission to cite their unpublished results.


   FOOTNOTES
 
* Corresponding author. Mailing address: Department of Molecular Sciences, University of Tennessee Health Science Center, 858 Madison Ave., Memphis, TN 38163. Phone: (901) 448-8215. Fax: (901) 448-8462. E-mail: mhowe{at}utmem.edu. Back


   REFERENCES
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 

  1. Artsimovitch, I. 1996. Activation of middle transcription of the phage Mu. Ph.D. thesis. The University of Tennessee, Memphis.
  2. Artsimovitch, I., and M. M. Howe. 1996. Transcription activation by the bacteriophage Mu Mor protein: analysis of promoter mutations in Pm identifies a new region required for promoter function. Nucleic Acids Res. 24:450-457.[Abstract/Free Full Text]
  3. Artsimovitch, I., K. Murakami, A. Ishihama, and M. M. Howe. 1996. Transcription activation by the bacteriophage Mu Mor protein requires the C-terminal regions of both alpha and sigma70 subunits of Escherichia coli RNA polymerase. J. Biol. Chem. 271:32343-32348.[Abstract/Free Full Text]
  4. Artsimovitch, I., M. Kahmeyer-Gabbe, and M. M. Howe. 1996. Distortion in the spacer region of Pm during activation of middle transcription of phage Mu. Proc. Natl. Acad. Sci. USA 93:9408-9413.[Abstract/Free Full Text]
  5. Attey, A., T. Belyaeva, N. Savery, J. Hoggett, N. Fujita, A. Ishihama, and S. J. W. Busby. 1994. Interactions between the cyclic AMP receptor protein and the alpha subunit of RNA polymerase at the Escherichia coli galactose operon P1 promoter. Nucleic Acids Res. 22:4375-4380.[Abstract/Free Full Text]
  6. Belyaeva, T. A., V. A. Rhodius, C. L. Webster, and S. J. W. Busby. 1998. Transcription activation at promoters carrying tandem DNA sites for the Escherichia coli cyclic AMP receptor protein: organisation of the RNA polymerase alpha subunits. J. Mol. Biol. 277:789-804.[CrossRef][Medline]
  7. Blatter, E. E., W. Ross, H. Tang, R. L. Gourse, and R. H. Ebright. 1994. Domain organization of RNA polymerase {alpha} subunit: C-terminal 85 amino acids constitute a domain capable of dimerization and DNA binding. Cell 78:889-896.[CrossRef][Medline]
  8. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.[CrossRef][Medline]
  9. Busby, S., and R. E. Ebright. 1994. Promoter structure, promoter recognition, and transcription activation in prokaryotes. Cell 79:743-746.[Medline]
  10. Busby, S., and R. H. Ebright. 1999. Transcription activation by catabolite activator protein (CAP). J. Mol. Biol. 293:199-213.[CrossRef][Medline]
  11. Chiang, L. W., and M. M. Howe. 1993. Mutational analysis of a C-dependent late promoter of bacteriophage Mu. Genetics 135:619-629.[Abstract]
  12. Estrem, S. T., T. Gaal, W. Ross, and R. L. Gourse. 1998. Identification of an UP element consensus sequence for bacterial promoters. Proc. Natl. Acad. Sci. USA 95:9761-9766.[Abstract/Free Full Text]
  13. Gaal, T., W. Ross, E. E. Blatter, H. Tang, X. Jia, V. V. Krishnan, N. Assa-Munt, R. H. Ebright, and R. L. Gourse. 1996. DNA-binding determinants of the alpha subunit of RNA polymerase: novel DNA-binding domain architecture. Genes Dev. 10:16-26.[Abstract/Free Full Text]
  14. Goosen, N., and P. van de Putte. 1987. Regulation of transcription, p. 41-52. In N. Symonds, A. Toussaint, P. van de Putte, and M. M. Howe (ed.), Phage Mu. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  15. Gourse, R. L., W. Ross, and T. Gaal. 2000. UPs and downs in bacterial transcription initiation: the role of the alpha subunit of RNA polymerase in promoter recognition. Mol. Microbiol. 37:687-695.[CrossRef][Medline]
  16. Gross, C. A., C. Chan, A. Dombroski, T. Gruber, M. Sharp, J. Tupy, and B. Young. 1998. The functional and regulatory roles of sigma factors in transcription. Cold Spring Harbor Symp. Quant. Biol. 63:141-155.
  17. Harley, C. B., and R. P. Reynolds. 1987. Analysis of E. coli promoter sequences. Nucleic Acids Res. 15:2343-2361.[Abstract/Free Full Text]
  18. Hawley, D. K., and W. R. McClure. 1982. Mechanism of activation of transcription initiation from the lambda PRM promoter. J. Mol. Biol. 157:493-525.[CrossRef][Medline]
  19. Hochschild, A., and S. L. Dove. 1998. Protein-protein contacts that activate and repress prokaryotic transcription. Cell 92:597-600.[CrossRef][Medline]
  20. Ishihama, A. 1981. Subunit of assembly of Escherichia coli RNA polymerase. Adv. Biophys. 14:1-35.[Medline]
  21. Kahmeyer-Gabbe, M., and M. M. Howe. 1996. Regulatory factors acting at the bacteriophage Mu middle promoter. J. Bacteriol. 178:1585-1592.[Abstract/Free Full Text]
  22. Krause, H. M., M. R. Rothwell, and N. P. Higgins. 1983. The early promoter of bacteriophage Mu: definition of the site of transcript initiation. Nucleic Acids Res. 11:5483-5495.[Abstract/Free Full Text]
  23. Kumaraswami, M., M. M. Howe, and H.-W. Park. 2004. Crystal structure of the Mor protein of bacteriophage Mu, a member of the Mor/C family of transcription activators. J. Biol. Chem. 279:16581-16590.[Abstract/Free Full Text]
  24. Li, X.-Y., and W. R. McClure. 1998. Characterization of the closed complex intermediate formed during transcription initiation by Escherichia coli RNA polymerase. J. Biol. Chem. 273:23549-23557.[Abstract/Free Full Text]
  25. Lonetto, M. A., M. Gribskov, and C. A. Gross. 1992. The {sigma}70 family: sequence conservation and evolutionary relationships. J. Bacteriol. 174:3843-3849.[Free Full Text]
  26. Lonetto, M. A., V. Rhodius, K. Lamberg, P. Kiley, S. Busby, and C. Gross. 1998. Identification of a contact site for different transcription activators in region 4 of the Escherichia coli RNA polymerase sigma70 subunit. J. Mol. Biol. 284:1353-1365.[CrossRef][Medline]
  27. Margolin, W., and M. M. Howe. 1990. Activation of the bacteriophage Mu lys promoter by Mu C protein requires the {sigma}70 subunit of Escherichia coli RNA polymerase. J. Bacteriol. 172:1424-1429.[Abstract/Free Full Text]
  28. Margolin, W., G. Rao, and M. M. Howe. 1989. Bacteriophage Mu late promoters: four late transcripts initiate near a conserved sequence. J. Bacteriol. 171:2003-2018.[Abstract/Free Full Text]
  29. Marrs, C. F., and M. M. Howe. 1990. Kinetics and regulation of transcription of bacteriophage Mu. Virology 174:192-203.[CrossRef][Medline]
  30. Mathee, K., and M. M. Howe. 1990. Identification of a positive regulator of the Mu middle operon. J. Bacteriol. 172:6641-6650.[Abstract/Free Full Text]
  31. Mathee, K., and M. M. Howe. 1993. Bacteriophage Mu Mor protein requires {sigma}70 to activate the Mu middle promoter. J. Bacteriol. 175:5314-5323.[Abstract/Free Full Text]
  32. McClure, W. R. 1985. Mechanism and control of transcription initiation in prokaryotes. Annu. Rev. Biochem. 54:171-204.[CrossRef][Medline]
  33. Murakami, K., J. T. Owens, T. A. Belyaeva, C. F. Meares, S. J. W. Busby, and A. Ishihama. 1997. Positioning of two alpha subunit carboxy-terminal domains of RNA polymerase at promoters by two transcription factors. Proc. Natl. Acad. Sci. USA 94:11274-11278.[Abstract/Free Full Text]
  34. Murakami, K., M. Kimura, J. T. Owens, C. F. Meares, and A. Ishihama. 1997. The two alpha subunits of Escherichia coli RNA polymerase are asymmetrically arranged and contact different halves of the DNA upstream element. Proc. Natl. Acad. Sci. USA 94:1709-1714.[Abstract/Free Full Text]
  35. Murakami, K. S., S. Masuda, and S. A. Darst. 2002. Structural basis of transcription initiation: RNA polymerase holoenzyme at 4 Å resolution. Science 296:1280-1284.[Abstract/Free Full Text]
  36. Murakami, K. S., S. Masuda, E. A. Campbell, O. Muzzin, and S. A. Darst. 2002. Structural basis of transcription initiation: an RNA polymerase holoenzyme-DNA complex. Science 296:1285-1290.[Abstract/Free Full Text]
  37. Negishi, T., N. Fujita, and A. Ishihama. 1995. Structural map of the {alpha} subunit of Escherichia coli RNA polymerase: structural domains identified by proteolytic cleavage. J. Mol. Biol. 248:723-728.[CrossRef][Medline]
  38. Niu, W., Y. Kim, G. Tau, T. Heyduk, and R. H. Ebright. 1996. Transcription activation at Class II CAP-dependent promoters: two interactions between CAP and RNA polymerase. Cell 87:1123-1134.[CrossRef][Medline]
  39. Ozoline, O. N., and M. A. Tsyganov. 1995. Structure of open promoter complexes with Escherichia coli RNA polymerase as revealed by the DNase I footprinting technique: compilation analysis. Nucleic Acids Res. 23:4533-4541.[Abstract/Free Full Text]
  40. Reznikoff, W. S., D. A. Siegele, D. W. Cowing, and C. A. Gross. 1985. The regulation of transcription initiation in bacteria. Annu. Rev. Genet. 19:355-387.[CrossRef][Medline]
  41. Ross, W., K. K. Gosink, J. Salomon, K. Igarashi, C. Zou, A. Ishihama, K. Severinov, and R. L. Gourse. 1993. A third recognition element in bacterial promoters: DNA binding by the {alpha} subunit of RNA polymerase. Science 262:1407-1413.[Abstract/Free Full Text]
  42. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
  43. Savery, N. J., G. S. Lloyd, S. J. W. Busby, M. S. Thomas, R. H. Ebright, and R. L. Gourse. 2002. Determinants of the C-terminal domain of the Escherichia coli RNA polymerase {alpha} subunit important for transcription at Class I cyclic AMP receptor protein-dependent promoters. J. Bacteriol. 184:2273-2280.[Abstract/Free Full Text]
  44. Simons, R. W., F. Houman, and N. Kleckner. 1987. Improved single and multicopy lac-based cloning vectors for protein and operon fusions. Gene 53:85-96.[CrossRef][Medline]
  45. Sollner-Webb, B., and R. H. Reeder. 1979. The nucleotide sequence of the initiation and termination sites for ribosomal RNA transcription in X. laevis. Cell 18:485-499.[CrossRef][Medline]
  46. Stoddard, S. F., and M. M. Howe. 1989. Localization and regulation of bacteriophage Mu promoters. J. Bacteriol. 17:3440-3448.
  47. Stoddard, S. F., and M. M. Howe. 1990. Characterization of the C operon transcript of bacteriophage Mu. J. Bacteriol. 172:361-371.[Abstract/Free Full Text]
  48. Studier, F. W., A. H. Rosenberg, J. J. Dunn, and J. W. Dubendorff. 1990. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185:60-89.[Medline]
  49. Suh, W. C., W. Ross, and M. T. Record, Jr. 1993. Two open complexes and a requirement for Mg2+ to open the lambda PR transcription start site. Science 259:358-361.[Abstract/Free Full Text]
  50. Tang, H., K. Severinov, A. Goldfarb, and R. H. Ebright. 1995. Rapid RNA polymerase genetics: one-day, no-column preparation of reconstituted recombinant Escherichia coli RNA polymerase. Proc. Natl. Acad. Sci. USA 92:4902-4906.[Abstract/Free Full Text]
  51. Toussaint, A., and J.-P. Lecocq. 1974. Sensitivity of bacteriophage Mu-1 development to rifampicin and streptolydigin. Mol. Gen. Genet. 129:185-188.[CrossRef][Medline]
  52. Zhang, G., and S. A. Darst. 1998. Structure of the Escherichia coli RNA polymerase {alpha} subunit amino-terminal domain. Science 281:262-266.[Abstract/Free Full Text]

Journal of Bacteriology, December 2004, p. 7858-7864, Vol. 186, No. 23
0021-9193/04/$08.00+0     DOI: 10.1128/JB.186.23.7858-7864.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, J.
Right arrow Articles by Howe, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, J.
Right arrow Articles by Howe, M. M.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Appl. Environ. Microbiol. Infect. Immun. Eukaryot. Cell
Mol. Cell. Biol. J. Virol. Microbiol. Mol. Biol. Rev.
ALL ASM JOURNALS